60 Degrees Pharmaceuticals regains Nasdaq minimum bid price compliance

60 DEGREES PHARMACEUTICALS, INC.

Received Nasdaq letter on Jan 10, 2024 confirming compliance with Bid Price Rule 5550(a)(2).
Closing bid price averaged $1.00 or more for 10 consecutive business days through Jan 9, 2024.
Previously received deficiency notice on Nov 2, 2023; delisting risk now resolved.
Company's common stock (SXTP) and warrants (SXTPW) continue trading on Nasdaq Capital Market.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.